1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Spain Pharmaceuticals and Healthcare Report Q4 2015

Spain Pharmaceuticals and Healthcare Report Q4 2015

  • October 2015
  • -
  • Business Monitor International
  • -
  • 101 pages

BMI View: Growth in the Spanish pharmaceutical market will remain sluggish over the coming years.Despite calls made by pharmaceutical companies for the implementation of a system that adequatelyrewards innovation and supports investment in future medicines, ongoing debt issues will result in theSpanish government remaining committed to fiscal consolidation. We expect the government to continue itspromotion of lower-value generic medicines over patented medicines.

Headline Expenditure Projections

- Pharmaceuticals: EUR24.71bn (USD33.11bn) in 2014 to EUR25.18bn (USD27.70bn) in 2015;+1.9% in local currency terms and -16.3% in US dollar terms. Forecast revised upwards from lastquarter.
- Healthcare: EUR90.72bn (USD121.56bn) in 2014 to EUR91.70bn (USD100.87bn) in 2015; +1.1% inlocal currency terms and -17.0% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Spain Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Spain 2011-2019) 15
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Spain 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Spain 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Spain 2013-2019) 28
Key Risks To BMI's Forecast Scenario 29
Macroeconomic Forecasts 30
Economic Analysis 30
Table: Economic Activity (Spain 2010-2019) 38
Pharmaceuticals Risk/Reward Index 39
Western Europe Risk/Reward Index 39
Spain Risk/Reward Index 44
Rewards 44
Risks 44
Market Overview 46
Industry Trends And Developments 47
Epidemiology 47
Healthcare Sector 49
Table: Regional Public Hospital Debt - Values In EURmn 50
Table: Healthcare Resources (Spain 2009-2014) 52
Table: Healthcare Personnel (Spain 2009-2014) 52
Table: Healthcare Activity (Spain 2009-2014) 53
Research and Development 53
Clinical Trials 54
Regulatory Development 57
Intellectual Property Issues 58
Parallel Trade 59
OTC Medicines 60
Generic Medicines 61
Pricing Regime 61
Reference Pricing System 63
Reimbursement Regime 66
Competitive Landscape 67
Pharmaceutical Sector 67
Generic Drug Sector 68
Biotechnology Sector 69
Pharmaceutical Retail 71
Company Profile 74
Almirall 74
Esteve 77
GlaxoSmithKline 80
Merck and Co 82
Novartis 84
Pfizer 86
Sanofi 88
Demographic Forecast 90
Demographic Outlook 90
Table: Population Headline Indicators (Spain 1990-2025) 91
Table: Key Population Ratios (Spain 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Spain 1990-2025) 92
Table: Population By Age Group (Spain 1990-2025) 92
Table: Population By Age Group % (Spain 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.